AfricaRegulatory
African Pharmaceutical Regulatory Intelligence
🇿🇦
Epirubicin Hydrochloride in South Africa
27 products registered with SAHPRA — 13 active
| Brand / Product | Reg. No. | Holder | Status | Expires |
|---|---|---|---|---|
| ASPEN EPIRUBICIN 20 mg/10 ml | 42/26/0529 | Pharmacare Limited û Woodmead | suspended | 18 Sept 2025 |
| ASPEN EPIRUBICIN 10 mg/5 ml | 42/26/0528 | Pharmacare Limited û Woodmead | suspended | 18 Sept 2025 |
| ASPEN EPIRUBICIN 50 mg/25 ml | 42/26/0530 | Pharmacare Limited û Woodmead | suspended | 18 Sept 2025 |
| ASPEN EPIRUBICIN 10 mg | 42/26/0018 | Pharmacare Limited û Woodmead | suspended | 18 Sept 2025 |
| ASPEN EPIRUBICIN 50 mg | 42/26/0019 | Pharmacare Limited û Woodmead | suspended | 18 Sept 2025 |
| ASPEN EPIRUBICIN 100 mg/50 ml | 42/26/0531 | Pharmacare Limited û Woodmead | suspended | 18 Sept 2025 |
| ASPEN EPIRUBICIN 200 mg/100 ml | 42/26/0532 | Pharmacare Limited û Woodmead | suspended | 18 Sept 2025 |
| EPIRUBICIN-HEXAL 50 mg/25 ML | 37/26/0126 | Sandoz South Africa (Pty) Ltd | suspended | 18 Aug 2025 |
| EPIRUBICIN HCL-HEXAL 10 mg/5 ML | 37/26/0125 | Sandoz South Africa (Pty) Ltd | suspended | 18 Aug 2025 |
| CIPLA-EPIRUBICIN 10 | 41/26/0979 | Cipla Medpro (Pty) Ltd | suspended | 16 Jul 2025 |
| FARMORUBICIN CSV 10 mg/5 ml | 32/26/0600 | Pfizer Laboratories (Pty) Ltd | suspended | 25 Mar 2024 |
| FARMORUBICIN CSV 50 mg/25 ml | 32/26/0602 | Pfizer Laboratories (Pty) Ltd | suspended | 25 Mar 2024 |
| EPIRUBICIN-HEXAL 200 mg/100 ML | 37/26/0128 | HEXAL PHARMA (SA) (PTY) LTD | suspended | 21 Jan 2022 |
| EPIRUBICIN-HEXAL 100 mg/50 ML | 37/26/0127 | HEXAL PHARMA (SA) (PTY) LTD | suspended | 21 Jan 2022 |
| EPIRUBICIN 10 mg/5 ml FRESENIUS | 45/26/0617 | Fresenius Kabi South Africa (Pty) Ltd | active | 26 Nov 2020 |
| EPIRUBICIN 200 mg/100 ml FRESENIUS | 45/26/0619 | Fresenius Kabi South Africa (Pty) Ltd | active | 26 Nov 2020 |
| EPIRUBICIN 50 mg/25 ml FRESENIUS | 45/26/0618 | Fresenius Kabi South Africa (Pty) Ltd | active | 26 Nov 2020 |
| HX-EPIRUBICIN 200 mg/100 ML | 37/26/0390 | Oethmaan Biosims (Pty) Ltd | active | 1 Jan 1900 |
| FARMORUBICIN RD 50 | Y/26/398 | Pfizer Laboratories (Pty) Ltd | active | 1 Jan 1900 |
| MERCK EPIRUBICIN 50 mg | 42/26/0745 | Viatris South Africa (Pty) Ltd | active | 1 Jan 1900 |
| MERCK EPIRUBICIN 10 mg | 42/26/0744 | Viatris South Africa (Pty) Ltd | active | 1 Jan 1900 |
| EPICORD 50 | 42/26/0897 | Accord Healthcare (Pty) Ltd | active | 1 Jan 1900 |
| EPICORD 10 | 42/26/0152 | Accord Healthcare (Pty) Ltd | active | 1 Jan 1900 |
| HX-EPIRUBICIN 10 mg/5 ML | 37/26/0387 | Oethmaan Biosims (Pty) Ltd | active | 1 Jan 1900 |
| HX-EPIRUBICIN 50 mg/25 ML | 37/26/0388 | Oethmaan Biosims (Pty) Ltd | active | 1 Jan 1900 |
| HX-EPIRUBICIN 100 mg/50 ML | 37/26/0389 | Oethmaan Biosims (Pty) Ltd | active | 1 Jan 1900 |
| FARMORUBICIN RD 10 | Y/26/397 | Pfizer Laboratories (Pty) Ltd | active | 1 Jan 1900 |
Epirubicin Hydrochloride — SAHPRA Registration Details
SAHPRA (South Africa) has 27 registered products containing Epirubicin Hydrochloride, of which 13 are currently active. Data is sourced directly from the official SAHPRA drug register and refreshed daily.
Track Epirubicin Hydrochloride registration expiry dates, monitor competitor approvals, and receive alerts when registration status changes. Create a free account to set up portfolio monitoring.